Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -155,636 | -86,372 | -59,978 | -63,386 | -44,703 |
| Depreciation Amortization | 2,773 | 2,530 | 2,286 | 1,642 | 1,067 |
| Accounts receivable | -9,704 | -2,347 | 25 | 24 | -57 |
| Accounts payable and accrued liabilities | -452 | 124 | -796 | 932 | -159 |
| Other Working Capital | 1,175 | -1,875 | 585 | 3,550 | 2,076 |
| Other Operating Activity | 108,290 | 10,362 | 8,651 | 6,765 | 7,775 |
| Operating Cash Flow | $-53,554 | $-77,578 | $-49,227 | $-50,473 | $-34,001 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -841 | -2,238 | -1,889 | -8,247 | -1,917 |
| Purchase Of Investment | N/A | N/A | 0 | -3,000 | -41,699 |
| Sale Of Investment | N/A | N/A | 0 | 38,200 | 80,684 |
| Investing Cash Flow | $-841 | $-2,238 | $-1,889 | $26,953 | $37,068 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,201 | 37,275 | 12,032 | 3,700 | 0 |
| Debt Repayment | -3,201 | 0 | -5,657 | -1,300 | 0 |
| Common Stock Issued | 228,014 | 38,066 | 62,265 | 30,199 | 1,104 |
| Other Financing Activity | 0 | 0 | 0 | -591 | -519 |
| Financing Cash Flow | $228,014 | $75,341 | $68,640 | $32,008 | $585 |
| Beginning Cash Position | 56,201 | 60,676 | 43,152 | 34,664 | 31,012 |
| End Cash Position | 229,821 | 56,201 | 60,676 | 43,152 | 34,664 |
| Net Cash Flow | $173,620 | $-4,475 | $17,524 | $8,488 | $3,652 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,554 | -77,578 | -49,227 | -50,473 | -34,001 |
| Capital Expenditure | -841 | -2,238 | -1,889 | -8,252 | -1,919 |
| Free Cash Flow | -54,395 | -79,816 | -51,116 | -58,725 | -35,920 |